Status:
RECRUITING
Intraoperative Ultrasonic Atomization of Lidocaine and Postoperative Pulmonary Complications
Lead Sponsor:
Jun Zhang
Conditions:
Postoperative Pulmonary Complications (PPCs)
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
There is high incidence of postoperative pulmonary complications (PPCs) in patients undergoing major abdominal surgeries.PPCs significantly prolongs the hospital stay of patients, increases their econ...
Detailed Description
Introduction Globally, over 313 million surgical procedures are performed annually, with postoperative pulmonary complications (PPCs) occurring in 5-33% of cases. PPCs, the second most common postoper...
Eligibility Criteria
Inclusion
- Patients who have signed the informed consent form and are willing to complete the study according to the protocol
- Age ≥18 years old and ≤90 years old
- ASA classification grades I-III
- Elective major non-cardiac surgery
- General anesthesia under tracheal intubation
- Monitor invasive arterial blood pressure
- The expected operation time ≥2 hours
Exclusion
- Untreated ischemic heart disease Severe cardiovascular and cerebrovascular diseases
- Severe asthma, pulmonary bullae, pneumothorax, bronchopleural fistula, etc
- Severe underlying liver and kidney diseases
- Age under 18 years old or over 90 years old
- The expected operation time is ≥2 hours
Key Trial Info
Start Date :
June 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT07000760
Start Date
June 6 2025
End Date
January 30 2026
Last Update
December 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Centre
Shanghai, Shanghai Municipality, China, 200032
2
Fudan University Shanghai Cancer Center
Shanghai, China